Max is a postdoctoral fellow with appointments in the departments of neuroscience and pharmacology and physiology researching the prevalence of cellular senescence following traumatic brain injury and its contributions to the onset of post-traumatic epilepsy, as well as the outcome of senolytic therapies on pathological measures following TBI. He is supported by a T32 Alzheimer’s and Age-Related Training Program grant, with previous support from a TL1 Translational Biosciences Program grant.
Max receives his B.A. in cognitive science from the University of Virginia, where he worked in the lab of Dr. Alban Gaultier researching the metabolic properties of T cells in animal models of multiple sclerosis. After graduation, he worked as a laboratory technician in the lab of Dr. Heather Ferris investigating the role of impaired brain cholesterol synthesis in Alzheimer’s Disease pathology, before joining the Georgetown University Interdisciplinary Program in Neuroscience for his Ph.D., where his thesis research examined the efficacy of novel small molecule tyrosine kinase inhibitors in alleviating Alzheimer’s Disease pathology in animal models under the mentorship of Dr. Charbel Moussa.
Outside the lab, Max enjoys spending time with his wife, daughter, and two dogs. He is an avid sportsman and has taken primarily to baseball, rock climbing, and golfing over the years.